329 related articles for article (PubMed ID: 15068859)
1. Co-delivery of pro-apoptotic BAX with a DNA vaccine recruits dendritic cells and promotes efficacy of autoimmune diabetes prevention in mice.
Li AF; Hough J; Henderson D; Escher A
Vaccine; 2004 Apr; 22(13-14):1751-63. PubMed ID: 15068859
[TBL] [Abstract][Full Text] [Related]
2. Pro-apoptotic DNA vaccination ameliorates new onset of autoimmune diabetes in NOD mice and induces foxp3+ regulatory T cells in vitro.
Li A; Ojogho O; Franco E; Baron P; Iwaki Y; Escher A
Vaccine; 2006 Jun; 24(23):5036-46. PubMed ID: 16621191
[TBL] [Abstract][Full Text] [Related]
3. A therapeutic DNA vaccination strategy for autoimmunity and transplantation.
Li A; Chen J; Hattori M; Franco E; Zuppan C; Ojogho O; Iwaki Y; Escher A
Vaccine; 2010 Feb; 28(8):1897-904. PubMed ID: 20188244
[TBL] [Abstract][Full Text] [Related]
4. Gene-gun biolistic immunization encoding glutamic acid decarboxylase: a model for studying Langerhans cell abnormalities and mimicry in the nonobese diabetic mouse.
Joussemet B; Vu AT; Sai P; Bach JM
Ann N Y Acad Sci; 2005 Jun; 1051():613-25. PubMed ID: 16127002
[TBL] [Abstract][Full Text] [Related]
5. Vaccination with glutamic acid decarboxylase plasmid DNA protects mice from spontaneous autoimmune diabetes and B7/CD28 costimulation circumvents that protection.
Balasa B; Boehm BO; Fortnagel A; Karges W; Van Gunst K; Jung N; Camacho SA; Webb SR; Sarvetnick N
Clin Immunol; 2001 May; 99(2):241-52. PubMed ID: 11318596
[TBL] [Abstract][Full Text] [Related]
6. [Mechanisms of human glutamic acid decarboxylase 65 DNA vaccine preventing diabetes in non-obese diabetic mice].
Luo JH; Zhou ZG; Jiang TJ; Pei JH; Li X; He L; Sun SG
Zhonghua Yi Xue Za Zhi; 2004 Nov; 84(21):1791-5. PubMed ID: 15631776
[TBL] [Abstract][Full Text] [Related]
7. DNA vaccination encoding glutamic acid decarboxylase can enhance insulitis and diabetes in correlation with a specific Th2/3 CD4 T cell response in non-obese diabetic mice.
Gauvrit A; Debailleul M; Vu AT; Sai P; Bach JM
Clin Exp Immunol; 2004 Aug; 137(2):253-62. PubMed ID: 15270841
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of both cellular and humoral responses to genetic immunization by co-administration of an antigen-expressing plasmid and a plasmid encoding the pro-apoptotic protein Bax.
Kinsey BM; Marcelli M; Song L; Bhogal BS; Ittmann M; Orson FM
J Gene Med; 2004 Apr; 6(4):445-54. PubMed ID: 15079819
[TBL] [Abstract][Full Text] [Related]
9. Prevention of autoimmune diabetes by immunogene therapy using recombinant vaccinia virus expressing glutamic acid decarboxylase.
Jun HS; Chung YH; Han J; Kim A; Yoo SS; Sherwin RS; Yoon JW
Diabetologia; 2002 May; 45(5):668-76. PubMed ID: 12107747
[TBL] [Abstract][Full Text] [Related]
10. Endogenous immune response to glutamic acid decarboxylase (GAD67) in NOD mice is modulated by adjuvant immunotherapy.
Qin HY; Elliott JF; Lakey JR; Rajotte RV; Singh B
J Autoimmun; 1998 Dec; 11(6):591-601. PubMed ID: 9878081
[TBL] [Abstract][Full Text] [Related]
11. Regulatory Th2-type T cell lines against insulin and GAD peptides derived from orally- and nasally-treated NOD mice suppress diabetes.
Maron R; Melican NS; Weiner HL
J Autoimmun; 1999 Jun; 12(4):251-8. PubMed ID: 10330296
[TBL] [Abstract][Full Text] [Related]
12. Transfusion of apoptotic beta-cells induces immune tolerance to beta-cell antigens and prevents type 1 diabetes in NOD mice.
Xia CQ; Peng R; Qiu Y; Annamalai M; Gordon D; Clare-Salzler MJ
Diabetes; 2007 Aug; 56(8):2116-23. PubMed ID: 17496235
[TBL] [Abstract][Full Text] [Related]
13. Flt-3 ligand as adjuvant for DNA vaccination augments immune responses but does not skew TH1/TH2 polarization.
Westermann J; Nguyen-Hoai T; Mollweide A; Richter G; Schmetzer O; Kim HJ; Blankenstein T; Dörken B; Pezzutto A
Gene Ther; 2004 Jul; 11(13):1048-56. PubMed ID: 15085174
[TBL] [Abstract][Full Text] [Related]
14. DNA vaccination with glutamic acid decarboxylase (GAD) generates a strong humoral immune response in BALB/c, C57BL/6, and in diabetes-prone NOD mice.
Wiest-Ladenburger U; Fortnagel A; Richter W; Reimann J; Boehm BO
Horm Metab Res; 1998 Oct; 30(10):605-9. PubMed ID: 9851666
[TBL] [Abstract][Full Text] [Related]
15. Coimmunization with RANTES plasmid polarized Th1 immune response against hepatitis B virus envelope via recruitment of dendritic cells.
Ma K; Xu W; Shao X; Yanyue ; Hu L; Xu H; Yuan Z; Zheng X; Xiong S
Antiviral Res; 2007 Nov; 76(2):140-9. PubMed ID: 17655942
[TBL] [Abstract][Full Text] [Related]
16. Retroviral delivery of GAD-IgG fusion construct induces tolerance and modulates diabetes: a role for CD4+ regulatory T cells and TGF-beta?
Song L; Wang J; Wang R; Yu M; Sun Y; Han G; Li Y; Qian J; Scott DW; Kang Y; Soukhareva N; Shen B
Gene Ther; 2004 Oct; 11(20):1487-96. PubMed ID: 15343360
[TBL] [Abstract][Full Text] [Related]
17. Gene delivery GAD 500 autoantigen by AAV serotype 1 prevented diabetes in NOD mice: transduction efficiency do not play important roles.
Han G; Wang R; Chen G; Wang J; Xu R; Feng J; Yu M; Wu X; Qian J; Shen B; Li Y
Immunol Lett; 2008 Jan; 115(2):110-6. PubMed ID: 18045698
[TBL] [Abstract][Full Text] [Related]
18. Switch from a dominant Th1-associated immune profile during the pre-diabetic phase in favour of a temporary increase of a Th3-associated and inflammatory immune profile at the onset of type 1 diabetes.
Ryden A; Stechova K; Durilova M; Faresjö M
Diabetes Metab Res Rev; 2009 May; 25(4):335-43. PubMed ID: 19382103
[TBL] [Abstract][Full Text] [Related]
19. Intradermal or oral delivery of GAD-encoding genetic vaccines suppresses type 1 diabetes.
Li AF; Escher A
DNA Cell Biol; 2003 Apr; 22(4):227-32. PubMed ID: 12823899
[TBL] [Abstract][Full Text] [Related]
20. The type and frequency of immunoregulatory CD4+ T-cells govern the efficacy of antigen-specific immunotherapy in nonobese diabetic mice.
Pop SM; Wong CP; He Q; Wang Y; Wallet MA; Goudy KS; Tisch R
Diabetes; 2007 May; 56(5):1395-402. PubMed ID: 17317763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
